US based contract research organization (CRO) Synteract has named Wendel Barr as the new CEO with immediate effect.
Subscribe to our email newsletter
Most recently, Barr worked as the chief operating officer and executive vice president of Covance.
Before Covance, he worked with Marconi Medical Systems as the vice president and general manager.
Barr said he is pleased to join Synteract at this point in its growth phase.
Synteract offers clinical trial services to biotechnology, medical device, and pharmaceutical companies.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.